Safety evaluation of combined PD1+CTLA4 inhibition concurrently to chemoradiotherapy (CRT) in localized muscle invasive bladder carcinoma (MIBC)

Category Primary study
JournalJournal of Clinical Oncology
Year 2021
This article has no abstract
Epistemonikos ID: 974d214f1e0c3888034c40c1a7a44ceb16950853
First added on: Feb 13, 2025